Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $1.731B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $373M | 21.6% | $12.22 | +246.6% | CLASS A ORD | 61559X104 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,025,000 | $91.63M | 5.3% | $24.66 | +70.6% | COM NEW | 21833P301 |
| ACLX | ARCELLX INC | 1,525,000 | $84.16M | 4.9% | $23.33 | +133.0% | COMMON STOCK | 03940C100 |
| PCVX | VAXCYTE INC | 1,100,000 | $83.06M | 4.8% | $53.56 | +27.1% | COM | 92243G108 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,790,462 | $75.43M | 4.4% | $16.70 | — | COM | 54300N103 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 8,325,000 | $72.43M | 4.2% | $11.03 | +26.6% | COM NEW | 30233G209 |
| RAPP | RAPPORT THERAPEUTICS INC | 2,940,283 | $68.39M | 4.0% | $23.15 | 0.0% | COM | 75383L102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,350,000 | $60.47M | 3.5% | $24.75 | +86.6% | COM | 22663K107 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,006,534 | $54.15M | 3.1% | $24.12 | -27.7% | COM | 28036F105 |
| — | MERUS N V | 840,000 | $49.7M | 2.9% | $47.13 | — | COM | N5749R100 |
| BBIO | BRIDGEBIO PHARMA INC | 1,858,351 | $47.07M | 2.7% | $17.77 | +53.9% | COM | 10806X102 |
| INSM | INSMED INC | 675,000 | $45.23M | 2.6% | $25.23 | +53.7% | COM PAR $.01 | 457669307 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 2,300,000 | $44.18M | 2.6% | $20.22 | -0.8% | ORDINARY SHARES | N62509109 |
| JANX | JANUX THERAPEUTICS INC | 1,050,000 | $43.98M | 2.5% | $28.97 | +62.1% | COM | 47103J105 |
| AXSM | AXSOME THERAPEUTICS INC | 400,000 | $32.2M | 1.9% | $74.04 | 0.0% | COM | 05464T104 |
| CGON | CG ONCOLOGY INC | 975,000 | $30.78M | 1.8% | $39.73 | -12.8% | COM | 156944100 |
| BBOT | HELIX ACQUISITION CORP II | 2,909,000 | $29.73M | 1.7% | $10.35 | -0.6% | CL A ORD SHS | G4444H101 |
| ALMS | ALUMIS INC | 2,147,400 | $28.56M | 1.6% | $13.30 | 0.0% | COM | 022307102 |
| PRAX | PRAXIS PRECISION MEDICINES I | 685,000 | $28.33M | 1.6% | $31.88 | +48.2% | COM NEW | 74006W207 |
| ABVX | ABIVAX SA | 2,130,000 | $28.16M | 1.6% | $10.70 | — | SPONSORED ADS | 00370M103 |
| BHVN | BIOHAVEN LTD | 801,963 | $27.84M | 1.6% | $43.60 | -9.3% | COM | G1110E107 |
| URGN | UROGEN PHARMA LTD | 1,650,000 | $27.69M | 1.6% | $14.22 | 0.0% | COM | M96088105 |
| PHVS | PHARVARIS N V | 1,466,460 | $27.57M | 1.6% | $21.48 | -5.3% | COM | N69605108 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,525,000 | $23.48M | 1.4% | $7.71 | +17.2% | COM | 03969K108 |
| SRPT | SAREPTA THERAPEUTICS INC | 125,000 | $19.75M | 1.1% | $128.46 | 0.0% | COM | 803607100 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,125,000 | $19.62M | 1.1% | $21.29 | 0.0% | COM | 230031106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 475,000 | $19.5M | 1.1% | $19.33 | +106.5% | COM | 76243J105 |
| — | CARGO THERAPEUTICS INC | 1,182,563 | $19.42M | 1.1% | $23.15 | — | COM | 14179K101 |
| — | Y-MABS THERAPEUTICS INC | 1,450,000 | $17.52M | 1.0% | $12.08 | — | COM | 984241109 |
| RNAM | AVIDITY BIOSCIENCES INC | 425,000 | $17.36M | 1.0% | $28.69 | 0.0% | COM | 05370A108 |
| BMEA | BIOMEA FUSION INC | 3,570,872 | $16.07M | 0.9% | $17.07 | -40.5% | COM | 09077A106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,611,600 | $14.55M | 0.8% | $11.45 | — | SPONSORED ADS | 152309100 |
| TARS | TARSUS PHARMACEUTICALS INC | 500,000 | $13.59M | 0.8% | $21.36 | +57.4% | COM | 87650L103 |
| SLN | SILENCE THERAPEUTICS PLC | 625,000 | $11.88M | 0.7% | $21.60 | — | ADS | 82686Q101 |
| AVBP | ARRIVENT BIOPHARMA INC | 515,000 | $9.553M | 0.6% | $20.17 | -11.6% | COM | 04272N102 |
| ENGN | ENGENE HOLDINGS INC | 1,000,000 | $9.43M | 0.5% | $12.24 | +4.8% | COM | 29286M105 |
| KRRO | KORRO BIO INC | 265,826 | $9.004M | 0.5% | $32.95 | +67.7% | COM | 500946108 |
| IDYA | IDEAYA BIOSCIENCES INC | 245,000 | $8.602M | 0.5% | $16.14 | +145.3% | COM | 45166A102 |
| IBRX | IMMUNITYBIO INC | 1,250,000 | $7.9M | 0.5% | — | — | Put | 45256X103 |
| GHRS | GH RESEARCH PLC | 593,043 | $6.915M | 0.4% | $20.43 | -41.2% | ORDINARY SHARES | G3855L106 |
| LNTH | LANTHEUS HLDGS INC | 75,000 | $6.022M | 0.3% | $67.75 | +8.3% | COM | 516544103 |
| STOK | STOKE THERAPEUTICS INC | 427,163 | $5.771M | 0.3% | $26.85 | -49.7% | COM | 86150R107 |
| — | MERSANA THERAPEUTICS INC | 2,600,000 | $5.226M | 0.3% | $4.48 | — | COM | 59045L106 |
| NGNE | NEUROGENE INC | 107,344 | $3.906M | 0.2% | $14.32 | +146.3% | COM | 64135M105 |
| SIGA | SIGA TECHNOLOGIES INC | 500,000 | $3.795M | 0.2% | — | — | Put | 826917106 |
| VYNE | VYNE THERAPEUTICS INC | 1,394,336 | $2.747M | 0.2% | $3.12 | -20.0% | COM | 92941V308 |
| CMPX | COMPASS THERAPEUTICS INC | 2,030,823 | $2.031M | 0.1% | $1.73 | -15.5% | COM | 20454B104 |
| — | VERVE THERAPEUTICS INC | 350,000 | $1.708M | 0.1% | $49.89 | — | COM | 92539P101 |
| — | RAPT THERAPEUTICS INC | 496,750 | $1.515M | 0.1% | $20.60 | — | COM | 75382E109 |